Five Immune Response Biomarkers Can Indicate Survival of COVID-19 Patients
Researchers have identified five immune response markers which, collectively created "antibody signatures" that could correctly classify both COVID-19 patients who recovered and those who did not survive the disease. More...14 Aug 2020
Powerful Machine-Learning Approach Helps Identify Hundreds of New Potential COVID-19 Drugs
Scientists at the University of California, Riverside (Riverside, CA, USA), have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2. More...14 Aug 2020
AI Algorithm for Blood Sugar Management Reduces Risk of Serious Complications in Diabetic COVID-19 Patients
Preliminary observations of COVID-19 patients with diabetes has inspired researchers from the University of Michigan (Ann Arbor, MI, USA) to develop an algorithm for glucose monitoring that could help combat the virus’ serious complications. More...14 Aug 2020
Philips Launches Rapid Equipment Deployment Kit to COVID-19 Response
Royal Philips (Amsterdam, the Netherlands) has launched its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses, technicians and hospital staff to quickly support critical care patient monitoring capabilities during the COVID-19 pandemic. More...14 Aug 2020
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Monitor Cart
Tryten S5
New
Digital Radiographic System
OMNERA 300M
In Other News
Phase 3 Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Begin Enrolling Adults at Risk of Infection
Only Dual Anti-Inflammatory/Antiviral Medication in Development to Treat COVID-19 Shows Promise in Study
Pre-Existing Immune Cell Memory That Recognizes Common Cold Coronaviruses Could Also Recognize and Fight off SARS-CoV-2
Phase 1/2 Study of Self-Replicating mRNA-Based COVID-19 Vaccine Completes Dosing
Gilead Seeks Full US FDA Approval for Experimental Coronavirus Drug Remdesivir for Treatment of COVID-19
Korean Biopharmaceutical Firm Celltrion Launches Both Antigen and Antibody Testing Kits in the US
China’s CanSino Biologics Begins Final Phase of Human Trials of COVID-19 Vaccine in Saudi Arabia
World’s First COVID-19 Vaccine Launched by Russia Ahead of Completion of Final Testing
New Recombinant Hyperimmune Drug Class Offers 100-Fold Higher Potency than Convalescent Serum Therapy for COVID-19
New COVID-19 Mobile Testing Device Diagnoses Infection Immediately via Breath Sample Using AI
Oral COVID-19 Vaccine Could Activate both Systemic and Mucosal Immunity for Protection against Coronavirus
Thermo Fisher Develops New COVID-19 Antibody Assay Targeting Transplant Community
Helix COVID-19 NGS Test One of the First Sequencing-Based COVID-19 Tests To Secure FDA Emergency Use Authorization
AI Technology Detects Deterioration in COVID-19 Patients by Identifying Predictive Patterns in Their Vital Signs
Newly-Engineered Antiviral Compounds Can Neutralize SARS-CoV-2 in Human Airway Cells
Newly-Developed Enzyme Could Treat Mysterious Multisystem Complications of COVID-19
BioMérieux SARS-CoV-2 Serology Tests Granted FDA Emergency Use Authorization
NIH Begins Clinical Trial of Antiviral Remdesivir Plus Immunomodulator Interferon Beta-1a in COVID-19 Patients
Pfizer Enters Into Multi-Year Agreement with Gilead to Manufacture Investigational Antiviral Remdesivir for COVID-19
AstraZeneca Signs Licensing Deal with China’s BioKangtai for 100 Million Doses of Oxford COVID-19 Vaccine by Year End
Human Trial of Pill That Could Reduce COVID-19 Related Lung Damage Begins At First US Clinical Trial Site
No 'Silver Bullet' for COVID-19, Widespread Vaccine Distribution Unlikely To Occur For Some Time, Says WHO
Antibodies Disappear in 10% of Coronavirus-Recovered Patients and 5% Test Positive Again In New Study
